The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Cardiovascular Implants Market Progress Between 2026 And 2030?
The cardiovascular implants market has shown significant expansion in recent years. It is anticipated to increase from $28.68 billion in 2025 to $30.52 billion in 2026, with a compound annual growth rate (CAGR) of 6.4%. This historical growth can be attributed to a higher incidence of cardiovascular diseases, an increase in interventional cardiology procedures, the expansion of hospital cardiac care units, the rising acceptance of implantable pacemakers, and the availability of advanced biomaterials.
The cardiovascular implants market is poised for robust expansion over the coming years. Its valuation is projected to reach $39.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This anticipated growth during the projection period stems from factors such as an expanding elderly demographic, a heightened need for less invasive cardiac interventions, the broadening scope of treatments for structural heart conditions, a stronger emphasis on individualized cardiovascular patient management, and continuous advancements in the composition and forms of implantable devices. Key developments anticipated during this timeframe involve the wider acceptance of minimally invasive cardiovascular implants, an uptick in the deployment of drug-eluting and bioabsorbable stents, an increasing inclination towards transcatheter heart valve operations, the proliferation of sophisticated cardiac rhythm management technologies, and a heightened emphasis on the sustained longevity of implants.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13399&type=smp
What Factors Are Contributing To The Growth Of The Cardiovascular Implants Market?
The increasing incidence of heart conditions is projected to boost the expansion of the cardiovascular implants market in the future. Heart disorders encompass diverse medical ailments impacting the heart and its blood vessels, such as coronary artery disease, heart failure, arrhythmias, and valve disorders. The widespread occurrence of heart diseases, like coronary artery disease and heart failure, fuels the need for cardiovascular implants, including stents and pacemakers, used in the treatment of these conditions. These implants provide support for the heart and circulation in individuals suffering from heart failure, assist the heart in maintaining a consistent rhythm, and monitor its rhythm. For example, a report released in September 2024 by the British Heart Foundation (BHF), a UK-based charity dedicated to funding research and promoting awareness of heart and circulatory diseases, indicated that around 7.6 million people in the UK are living with heart and circulatory diseases. Projections suggest that by 2030, the count of individuals affected by heart and circulatory diseases in the UK could grow by 1 million, and by 2040, this number might further expand by 2 million, beyond current figures. Consequently, the increasing prevalence of heart disorders is a key factor propelling the expansion of the cardiovascular implants market.
How Is The Cardiovascular Implants Market Categorized Across Its Segment Groups?
The cardiovascular implants market covered in this report is segmented –
1) By Product: Coronary Stent, Implantable Cardioverter Defibrillator (ICD), Heart Valve, Implanted Cardiac Pacemaker, Cardiac Resynchronization Therapy (CRT) Devices, Peripheral Stent
2) By Material: Metals and Alloys, Polymers, Biological Materials
3) By Application: Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Other Applications
4) By End-Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers
Subsegments:
1) By Coronary Stent: Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents
2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD, Dual-Chamber ICD, Biventricular ICD
3) By Heart Valve: Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves
4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker, Dual-Chamber Pacemaker, Biventricular Pacemaker
5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers), CRT-D Devices (Defibrillators)
6) By Peripheral Stent: Carotid Artery Stents, Renal Artery Stents, Femoral Artery Stents
What Trends Are Shaping The Future Of The Cardiovascular Implants Market?
Major companies within the cardiovascular implants market are increasingly focusing on incorporating advanced technology, particularly artificial intelligence (AI), to maximize their profits and enhance the precision of patient care and treatment. The progression of cardiac monitoring technology involves consistently tracking and recording a patient’s heart activity to aid in the diagnosis and management of heart-related conditions. For instance, in June 2023, BIOTRONIK SE & Co. KG, a medical technology company headquartered in Germany, performed the first global implantation of its BIOMONITOR IV implantable cardiac monitor (ICM). The BIOMONITOR IV is an advanced ICM that merges BIOTRONIK’s SmartECG technology with artificial intelligence to decrease false-positive detections by 86% while still capturing 98% of genuine cardiac events. In addition to its sophisticated artificial intelligence, the BIOMONITOR IV provides several other advantages for both patients and healthcare professionals. Its extended battery life and wireless connectivity ensure smooth data transmission and remote monitoring, thereby reducing the need for frequent in-person clinic visits.
Which Firms Are Influencing Competition In The Cardiovascular Implants Market?
Major companies operating in the cardiovascular implants market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd
Get The Full Cardiovascular Implants Market Report:
https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report
Where Is The Cardiovascular Implants Market Primarily Concentrated By Region?
North America was the largest region in the cardiovascular implants market in 2025. The regions covered in the cardiovascular implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cardiovascular Implants Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=13399&type=smp
Browse Through More Reports Similar to the Global Cardiovascular Implants Market 2026, By The Business Research Company
Cardiovascular Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report
Cardiovascular Surgery Devices And Equipment Market Report 2026
Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model